0001209191-15-003771.txt : 20150112 0001209191-15-003771.hdr.sgml : 20150112 20150112181755 ACCESSION NUMBER: 0001209191-15-003771 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150108 FILED AS OF DATE: 20150112 DATE AS OF CHANGE: 20150112 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NUVASIVE INC CENTRAL INDEX KEY: 0001142596 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 330768598 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7475 LUSK BLVD. CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: (858) 909-1800 MAIL ADDRESS: STREET 1: 7475 LUSK BLVD. CITY: SAN DIEGO STATE: CA ZIP: 92121 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lukianov Alexis V CENTRAL INDEX KEY: 0001289410 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50744 FILM NUMBER: 15522913 MAIL ADDRESS: STREET 1: 7475 LUSK BLVD. CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-01-08 0 0001142596 NUVASIVE INC NUVA 0001289410 Lukianov Alexis V 7475 LUSK BLVD SAN DIEGO CA 92121 1 1 0 0 Chairman & CEO Common Stock 2015-01-08 4 M 0 18750 18.31 A 186181 D Common Stock 2015-01-08 4 F 0 11298 50.39 D 174883 D Common Stock 2015-01-12 4 S 0 7452 49.6871 D 167431 D Employee Stock Option (Right to Buy) 18.31 2015-01-08 4 M 0 18750 0.00 A 2016-01-03 Common Stock 18750 0 D Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive or purchase (as appropriate) shares pursuant to previously disclosed Company equity awards. Payment of exercise price and tax liability by Issuer's withholding of shares incident to the respective option exercise. The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the Reporting Person on November 15, 2014, which is intended to comply with Rule 10b5-1. Weighted average from 73 transactions with prices ranging from $49.4200 to $50.0750. Upon request by the Commission staff, the Issuer or a security holder of the Issuer, the Reporting Person will undertake to provide full information regarding the number of shares sold at each separate price. The option, representing a right to purchase a total of 244,539 shares, became exercisable as follows: 25% of the shares vested on January 3, 2007; the remaining shares vested monthly thereafter so that all shares were fully vested as of January 3, 2010, subject to continued employment through each vesting period. /s/ Jason M. Hannon, Attorney-in-Fact for Alexis V. Lukianov 2015-01-12